Cited by 405Cannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on BehaviorNicotinic Acetylcholine Receptors Study

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

Cohen, C., Perrault, G., Voltz, C., Steinberg, R., Soubrié, P.·2002·Behavioural Pharmacology

DOI 10.1097/00008877-200209000-00018

Open this paper in CoChat — free account

Abstract

The central CB(1) cannabinoid receptor has recently been implicated in brain reward function. In the present study we evaluated first the effects of the selective CB(1) receptor antagonist, SR141716, on the motivational effects of nicotine in the rat. Administration of SR141716 (0.3 and 1 mg/kg) decreased nicotine self-administration (0.03 mg/kg/injection). SR141716 (0.3-3 mg/kg) neither substituted for nicotine nor antagonized the nicotine cue in a nicotine discrimination procedure, but dose-dependently (0.01-1 mg/kg) antagonized the substitution of nicotine for D-amphetamine, in rats trained to discriminate D-amphetamine. Secondly, using brain microdialysis, SR141716 (1-3 mg/kg) blocked nicotine-induced dopamine release in the shell of the nucleus accumbens (NAc) and the bed nucleus of the stria terminalis. To investigate whether SR141716 would block the dopamine-releasing effects of another drug of abuse, we extended the neurochemical study to the effect of ethanol, consumption of which in rodents is reduced by SR141716. Dopamine release induced by ethanol in the NAc was also reduced by SR141716 (3 mg/kg). These results suggest that activation of the endogenous cannabinoid system may participate in the motivational and dopamine-releasing effects of nicotine and ethanol. Thus, SR141716 may be effective in reduction of alcohol consumption, as previously suggested, and as an aid for smoking cessation.

Integrity signals

Registry

Crossref · 10.1097/00008877-200209000-00018

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
Berridge, K. C., & Robinson, T. E. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00019-8 · Cited by 4,127
Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice
Ledent, C. A., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Impérato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,628
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,762
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking
Ikemoto, S., & Panksepp, J. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00023-5 · Cited by 1,450
Cannabinoid and Heroin Activation of Mesolimbic Dopamine Transmission by a Common µ 1 Opioid Receptor Mechanism
Tanda, G., Pontieri, F. E., & Chiara, G. D. (1997) · Science · doi:10.1126/science.276.5321.2048 · Cited by 1,085
Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D. (1996) · Nature · doi:10.1038/382255a0 · Cited by 1,073
The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
Corrigall, W. A., Franklin, K. B. J., Coen, K. M., & Clarke, P. B. S. (1992) · Psychopharmacology · doi:10.1007/bf02245149 · Cited by 829
Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area
Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)90401-4 · Cited by 740
Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats
Imperato, A., Mulas, A., & Di Chiara, G. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90629-1 · Cited by 693
Modulation of transmitter release via presynaptic cannabinoid receptors
Schlicker, E., & Kathmann, M. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01805-8 · Cited by 671
Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry
Mailleux, P., & Vanderhaeghen, J. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90409-u · Cited by 660
Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors
Arnone, M., Maruani, J., Chaperon, F., Thiébot, M.-H., Poncelet, M., Soubrié, P., & Fur, G. L. (1997) · Psychopharmacology · doi:10.1007/s002130050326 · Cited by 593
Nicotine maintains robust self-administration in rats on a limited-access schedule
Corrigall, W. A., & Coen, K. M. (1989) · Psychopharmacology · doi:10.1007/bf00589894 · Cited by 578
Animal models of drug craving
Markou, A., Weiss, F., Gold, L. H., Caine, S. B., Schulteis, G., & Koob, G. F. (1993) · Psychopharmacology · doi:10.1007/bf02244907 · Cited by 559
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
Herkenham, M. A., Lynn, A. B., de Costa, B. R., & Richfield, E. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90970-7 · Cited by 515
Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats
Weiss, F., Parsons, L. H., Schulteis, G., Hyytiä, P., Lorang, M. T., Bloom, F. E., & Koob, G. F. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-10-03474.1996 · Cited by 457
Functional interaction between opioid and cannabinoid receptors in drug self-administration.
Navarro, M., Carrera, M. R. A., Fratta, W., Valverde, O., Cossu, G., Fattore, L., Chowen, J. A., Gómez, R., del Arco, I., Villanúa, M. A., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05344.2001 · Cited by 378
Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra
French, E. D., Dillon, K. A., & Wu, X. (1997) · Neuroreport · doi:10.1097/00001756-199702100-00014 · Cited by 375
A Role for the Bed Nucleus of the Stria Terminalis, But Not the Amygdala, in the Effects of Corticotropin-Releasing Factor on Stress-Induced Reinstatement of Cocaine Seeking
Erb, S. M., & Stewart, J. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-20-j0006.1999 · Cited by 347
Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys
Tanda, G., Munzar, P., & Goldberg, S. R. (2000) · Nature Neuroscience · doi:10.1038/80577 · Cited by 347
Δ9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis
Chen, J., Paredes, W. M., Li, J., Smith, D. M., Lowinson, J. H., & Gardner, E. L. (1990) · Psychopharmacology · doi:10.1007/bf02245916 · Cited by 329
Behavioural and biochemical evidence for interactions between Δ9‐tetrahydrocannabinol and nicotine
Valjent, E., Mitchell, J., Besson, M., Caboche, J., & Maldonado, R. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704479 · Cited by 325
Involvement of central cannabinoid (CB 1 ) receptors in the establishment of place conditioning in rats
Chaperon, F., Soubrié, P., Puech, A. J., & Thiébot, M.-H. (1998) · Psychopharmacology · doi:10.1007/s002130050518 · Cited by 292
Selective dopamine antagonists reduce nicotine self-administration
Corrigall, W. A., & Coen, K. M. (1991) · Psychopharmacology · doi:10.1007/bf02244174 · Cited by 282
Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse
Cossu, G., Ledent, C. A., Fattore, L., Impérato, A., Böhme, G. A., Parmentier, M., & Fratta, W. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00311-9 · Cited by 275
Conditioned place preference induced by Δ9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward
Lepore, M., Vorel, S. R., Lowinson, J. H., & Gardner, E. L. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00191-8 · Cited by 237
Δ9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors
French, E. D. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00278-4 · Cited by 236
REDUCTION OF VOLUNTARY ETHANOL INTAKE IN ETHANOL-PREFERRING sP RATS BY THE CANNABINOID ANTAGONIST SR-141716
Colombo, G., Agabio, R., Fà, M., Guano, L., Loche, A., Reali, R., & Gessa, G. L. (1998) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a008368 · Cited by 226
Parameters of self-administration of cocaine in rats under a progressive-ratio schedule
Depoortère, R., Li, D. H., Lane, J. D., & Emmett‐Oglesby, M. W. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90503-l · Cited by 215
A behavioural model to reveal place preference to Δ9-tetrahydrocannabinol in mice
Valjent, E., & Maldonado, R. J. (2000) · Psychopharmacology · doi:10.1007/s002130050013 · Cited by 214
N-methyl-d-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens
Schilström, B., Nomikos, G. G., Nisell, M., Hertel, P., & Svensson, T. H. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00243-1 · Cited by 207
Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice
Martellotta, M. C., Cossu, G., Fattore, L., Gessa, G. L., & Fratta, W. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00052-9 · Cited by 205
Infusion of Nicotine in the Ventral Tegmental Area or the Nucleus Accumbens of the Rat Differentially Affects Accumbal Dopamine Release
Nisell, M., Nomikos, G. G., & Svensson, T. H. (1994) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1994.tb00373.x · Cited by 204
The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716
Gallate, J. E., & McGregor, I. S. (1999) · Psychopharmacology · doi:10.1007/s002130050893 · Cited by 199
Effects of SR141716A on Ethanol and Sucrose Self-Administration
Freedland, C. S., Sharpe, A. L., Samson, H. H., & Porrino, L. J. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02209.x · Cited by 189
Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats
Fattore, L., Cossu, G., Martellotta, C., & Fratta, W. (2001) · Psychopharmacology · doi:10.1007/s002130100734 · Cited by 187
Experimental approach to individual vulnerability to psychostimulant addiction
Deminiere, J. M., Piazza, P. V., Le Moal, M., & Simon, H. (1989) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(89)80023-5 · Cited by 177
Stimulation ofIn VivoDopamine Transmission in the Bed Nucleus of Stria Terminalis by Reinforcing Drugs
Carboni, E., Silvagni, A., Rolando, M. T. P., & Chiara, G. D. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-20-j0002.2000 · Cited by 173
Aversive effects of the synthetic cannabinoid CP 55,940 in rats
McGregor, I. S., Issakidis, C. N., & Prior, G. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02066-7 · Cited by 169
Endogenous cannabinoids as an aversive or counter-rewarding system in the rat.
Sañudo-Peña, M., Tsou, K., Delay, E., Hohman, A. G., Force, M., & Walker, J. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)13424-3 · Cited by 156
Cannabinoid receptors and reward in the rat: a conditioned place preference study
Cheer, J. F., Kendall, D. A., & Marsden, C. A. (2000) · Psychopharmacology · doi:10.1007/s002130000481 · Cited by 151
Systemic Nicotine Stimulates Dopamine Release in Nucleus Accumbens: Re-evaluation of the Role ofN-Methyl-d-aspartate Receptors in the Ventral Tegmental Area
Fu, Y., Matta, S. G., Gao, W., Brower, V. G., & Sharp, B. M. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39093-7 · Cited by 139
The dopamine D-1 receptor antagonist SCH 23390 injected into the dorsolateral bed nucleus of the stria terminalis decreased cocaine reinforcement in the rat
Epping-Jordan, M. P., Markou, A., & Koob, G. F. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01190-6 · Cited by 135
The Pharmacology of (-)-Nicotine and Novel Cholinergic Channel Modulators
Brioni, J. D., Decker, M. W., Sullivan, J. P., & Arnerić, S. P. (1996) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60950-3 · Cited by 134
THC-induced place and taste aversions in Lewis and Sprague-Dawley rats.
Parker, L. A., & Gillies, T. (1995) · Behavioral Neuroscience · doi:10.1037//0735-7044.109.1.71 · Cited by 128
Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB1 receptor knockout mice
Mascia, M. S., Obinu, M. C., Ledent, C. A., Parmentier, M., Böhme, G. A., Impérato, A., & Fratta, W. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00656-1 · Cited by 125
Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys
Harris, R. T., Waters, W., & McLendon, D. M. (1974) · Psychopharmacology · doi:10.1007/bf00426679 · Cited by 123
THC-induced place and taste aversions in Lewis and Sprague-Dawley rats.
Parker, L. A., & Gillies, T. (1995) · Behavioral Neuroscience · doi:10.1037/0735-7044.109.1.71 · Cited by 122
Dopaminergic mediation of the interoceptive cue produced by d-amphetamine in rats
Schechter, M., & Cook, P. G. (1975) · Psychopharmacology · doi:10.1007/bf00429551 · Cited by 104
Low endogenous dopamine function in brain predisposes to high alcohol preference and consumption: reversal by increasing synaptic dopamine.
George, S. R., Fan, T., Ng, G., Jung, S., O’Dowd, B. F., & Naranjo, C. A. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09574-6 · Cited by 103
Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers.
de Fonseca, F. R., Roberts, A. J., Bilbao, A., Koob, G. F., & Navarro, M. (1999) · PubMed · Cited by 103
CB1 cannabinoid receptor agonist WIN 55, 212-2 decreases intravenous cocaine self-administration in rats
Fattore, L. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00059-5 · Cited by 100
Discrimination and self-administration of nicotine by inbred strains of mice
Stolerman, I. P., Naylor, C. G., Elmer, G. I., & Goldberg, S. R. (1999) · Psychopharmacology · doi:10.1007/s002130050837 · Cited by 99
Failure of Δ9-tetrahydrocannabinol and CP 55,940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys
Mansbach, R. S., Nicholson, K. L., Martin, B. R., & Balster, R. L. (1994) · Behavioural Pharmacology · doi:10.1097/00008877-199404000-00014 · Cited by 97
Evidence for an involvement of D1 and D2 dopamine receptors in mediating nicotine-induced hyperactivity in rats
O‘Neill, M. F., Dourish, C. T., & Iversen, S. D. (1991) · Psychopharmacology · doi:10.1007/bf02246034 · Cited by 95
Control of behavior by intravenous nicotine injections in laboratory animals
Goldberg, S. R., Spealman, R. D., Risner, M. E., & Henningfield, J. E. (1983) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(83)90408-2 · Cited by 88
Nicotine injections as the conditioned stimulus in discrimination learning
Morrison, C. F., & Stephenson, J. A. (1969) · Psychopharmacology · doi:10.1007/bf00403710 · Cited by 87
The Reinforcing Properties of Nicotine are Associated with a Specific Patterning of c‐fos Expression in the Rat Brain
Pagliusi, S. R., Tessari, M., DEVEVEY, S., Chiamulera, C., & Pich, E. M. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01188.x · Cited by 79
Is nicotine more addictive than cocaine?
Henningfield, J. E., Cohen, C., & SLADE, J. D. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01809.x · Cited by 78
SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats
Deroche‐Gamonet, V., Moal, M. L., Piazza, P. V., & Soubrié, P. (2001) · Psychopharmacology · doi:10.1007/s002130100804 · Cited by 72
Reinforcing Effects of Nicotinic Compounds Intravenous Self-administration in Drug-Naive Mice
Rasmussen, T. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00003-3 · Cited by 71
ARE ANANDAMIDE AND CANNABINOID RECEPTORS INVOLVED IN ETHANOL TOLERANCE? A REVIEW OF THE EVIDENCE
Hungund, B. L. (2000) · Alcohol and Alcoholism · doi:10.1093/alcalc/35.2.126 · Cited by 58
THE DRAMBALLET STUDIO
BELOVA, E. (1996) · Experiment · doi:10.1163/2211730x96x00144 · Cited by 53
Preferential involvement of D 3 versus D 2 dopamine receptors in the effects of dopamine receptor ligands on oral ethanol self-administration in rats
Cohen, C., Perrault, G., & Sanger, D. J. (1998) · Psychopharmacology · doi:10.1007/s002130050792 · Cited by 50
Acquisition of Nicotine Discrimination and Discriminative Stimulus Effects of Nicotine in Rats Chronically Exposed to Caffeine
Ga̧sior, M., Shoaib, M., Yaşar, S., Jaszyna, M., & Goldberg, S. R. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38058-9 · Cited by 48
Dopamine mechanisms play at best a small role in the nicotine discriminative stimulus
Corrigall, W. A., & Coen, K. M. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90353-0 · Cited by 48
Interaction of nicotine with dopaminergic mechanisms assessed through drug discrimination and rotational behaviour in rats
Reavill, C. A., & Stolerman, I. P. (1987) · Journal of Psychopharmacology · doi:10.1177/026988118700100408 · Cited by 44
Effects of D 1 dopamine receptor agonists on oral ethanol self-administration in rats: comparison with their efficacy to produce grooming and hyperactivity
Cohen, C., Perrault, G., & Sanger, D. J. (1999) · Psychopharmacology · doi:10.1007/s002130050868 · Cited by 38
The role of monoamine neurotransmitter systems in the nicotine discriminative stimulus
Mansbach, R. S., Rovetti, C. C., & Freedland, C. S. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00085-4 · Cited by 38
Metabolic Mapping of the Effects of Win 55212–2 Intravenous Administration in the Rat
Pontieri, F. E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00064-0 · Cited by 35
Task-specific effects of nicotine in ratsIntracranial self-stimulation and locomotor activity
Schaêfer, G., & MICHAEL, R. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90033-x · Cited by 35
Activity of SH141716 on post-reinforcement pauses in operant responding for sucrose reward in rats
Perio, A., Barnouin, M. C., Poncelet, M., & Soubrié, P. (2001) · Behavioural Pharmacology · doi:10.1097/00008877-200112000-00009 · Cited by 29
Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. I. Biochemical profile.
Curet, O., Damoiseau, G., Aubin, N., Sontag, N., Rovei, V., & JARREAU, F. ‐. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12817-6 · Cited by 28
Characterization of the Discriminative Stimulus Produced by the Dopamine Antagonist Tiapride
Cohen, C., Sanger, D. J., & Perrault, G. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37047-8 · Cited by 21
Discriminative stimulus effects of intravenous nicotine in squirrel monkeys
Takada, K., Hagen, T. J., Cook, J. M., Goldberg, S. R., & Katz, J. L. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90452-2 · Cited by 20

Research works printed but not linked: 3

Cohen, 1999b, NIDA Research Monograph US Department of Health Human Services, 180, 197
deFonseca, 1999, Acta Pharmacol Sin, 20, 1109
De Vries, 2001, Nature, 7, 1511

Sorted by citations

The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno‐Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,595
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 978
The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse?
Pierce, R. C., & Kumaresan, V. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.04.016 · Cited by 913
Cannabinoid physiology and pharmacology: 30 years of progress
Howlett, A. C., Breivogel, C. S., Childers, S. R., Deadwyler, S. A., Hampson, R. E., & Porrino, L. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.030 · Cited by 608

See all 405

Authors: Cohen, C., Perrault, G., Voltz, C., Steinberg, R., & Soubrié, P.
Affiliations: Sanofi (France) (FR)
Corresponding author: Cohen, C.
Venue: Behavioural Pharmacology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2002-09
Volume: 13
Issue: 5
Pages: 451-463
ISSN: 0955-8810 (ISSN-L)
DOI: 10.1097/00008877-200209000-00018
OpenAlex: W2001109168
Cited by: 396
References: 77
Citations by year: 2026: 5 · 2025: 2 · 2024: 4 · 2023: 11 · 2022: 9 · 2021: 7 · 2020: 13 · 2019: 8 · 2018: 8 · 2017: 11 · 2016: 20 · 2015: 14 · 2014: 9 · 2013: 19 · 2012: 16
FWCI: 16.34
Type: journal article
Language: en
Open access: closed
Locations: Behavioural Pharmacology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
Keywords: SR141716, nicotine self-administration, dopamine release, nucleus accumbens shell, bed nucleus of the stria terminalis, endocannabinoid system, drug reward, alcohol consumption reduction, smoking cessation
MeSH terms: Rimonabant, Ethanol, Animals, Brain Chemistry, Central Nervous System Depressants, Discrimination Learning, Dopamine, Extracellular Space, Male, Motivation, Nicotine, Nucleus Accumbens, Piperidines, Pyrazoles, Receptors, Drug, Reinforcement, Psychology, Self Administration, Rats, Sprague-Dawley, Rats, Wistar, Microdialysis, Nicotinic Agonists, Nicotinic Antagonists, Receptors, Cannabinoid, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks